PANCREAZE
AssetAlso called PANCREASE MT, pancrelipase
Provides pancreatic enzyme therapy.
- Stage
- Approved
- Modality
- Protein or enzyme
- Target
- Not known
- 1
- Indication
- 0
- Trials
- 1
- Developer
Approved by the FDA on Apr 12, 2010 (BLA022523). FDA
Indications
1Exocrine pancreatic insufficiency due to cystic fibrosis or other conditions
Approved, vivus.com
In the full profile
- Owner and partners1
Every asset’s record: target, stage, trials and the evidence behind it.